AQR Capital Management
KMTS

AQR Capital Management’s Kestra Medical Technologies KMTS Stock Holding History

AQR Capital Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$825K Buy
+32,447
New +$679K ﹤0.01% 3113
2026
Q1 		– Sell
-8,340
Closed -$221K – 3836
2025
Q4 		$221K Buy
+8,340
New +$215K ﹤0.01% 3313

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

AQR Capital Management's KMTS Position: Q2 2026 in Review

AQR Capital Management opened a new position in Kestra Medical Technologies (KMTS) in Q2 2026: 32,447 shares worth $825K. The stake represents ﹤0.01% of the portfolio and ranks #3113 among its holdings. This is a return to the name: AQR Capital Management previously reported a position in KMTS as recently as Q4 2025.

AQR Capital Management first reported a position in KMTS in Q4 2025 and has held it in 2 quarters since. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • AQR Capital Management held 32,447 shares of Kestra Medical Technologies worth $825K as of Q2 2026.
  • Kestra Medical Technologies was a new AQR Capital Management position in Q2 2026.
  • Kestra Medical Technologies made up ﹤0.01% of AQR Capital Management's portfolio in Q2 2026, its #3113 holding.
  • AQR Capital Management first reported a position in Kestra Medical Technologies in Q4 2025 and has held it in 2 quarters since.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.